System and Method for Geometrodynamic Mapping of Metabolic States using Accelerated Magnetic Resonance Spectroscopic Imaging
Description
Background of the Invention
The accurate, non-invasive assessment of tissue metabolism is a central goal in modern medicine. It is a well-established principle that metabolic and physiological alterations often precede the manifestation of gross anatomical or structural abnormalities visible with conventional imaging techniques.1 The ability to map these early biochemical changes holds immense promise for the early diagnosis of disease, the precise characterization of pathophysiology, and the objective monitoring of therapeutic response across a wide range of clinical disciplines, including oncology, neurology, and the study of systemic metabolic disorders. However, the development of a technology that can fulfill this promise in a clinically practical manner has been a long-standing and unmet challenge. The prior art is characterized by a series of compromises, with each existing modality possessing fundamental limitations that have prevented its widespread adoption for routine, comprehensive metabolic assessment.